Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer

BACKGROUND: The clinical implication of Ras/Raf/ERK pathway activity in breast cancer tissue and its association with response to chemotherapy is controversial. We aimed to explore the value of p90RSK phosphorylation, a downstram molecule of the pathway, in predicting chemotherapy response in breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Hyeong-Gon, Yi, Jae Kyo, Kim, Hee Sung, Lee, Hea Young, Lee, Kyung-Min, Yi, Minju, Ahn, Sookyung, Shin, Hee-Chul, Ju, Ji-hyun, Shin, Incheol, Han, Wonshik, Noh, Dong-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523086/
https://www.ncbi.nlm.nih.gov/pubmed/23216670
http://dx.doi.org/10.1186/1471-2407-12-585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523086/
https://www.ncbi.nlm.nih.gov/pubmed/23216670
http://dx.doi.org/10.1186/1471-2407-12-585

Ejemplares similares